Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120925
Published online Sep 9, 2026. doi: 10.5409/wjcp.120925
Published online Sep 9, 2026. doi: 10.5409/wjcp.120925
Table 1 Clinical timeline: Episodes of acute liver failure
| Age | Trigger | Key laboratory findings | Treatment | Outcome |
| 19 months | Fever + URTI; antibiotics and paracetamol given | ALT: 1840, AST: 2210, Bili: 340 μmol/L, GGT: 18 (low), INR: 2.8, pancytopenia | Corticosteroids, IV fluids, nutritional support | Partial improvement; no normalisation |
| 21 months | Febrile illness | ALT: 980, AST: 1140, Bili: 210, GGT: 20, INR: 2.1 | Supportive care; steroids repeated | Partial improvement; ongoing enzyme elevation |
| 22 months | Febrile UTI | ALT: 2100, AST: 2450, Bili: 380 μmol/L, INR: 3.1, GGT: 24, Plt: 62 | Antibiotics + supportive care | Ongoing follow-up; genetic counselling initiated |
Table 2 Laboratory findings across three episodes of acute liver failure
| Parameter | Episode 1 (19 months) | Post-Rx (20 months) | Episode 2 (21 months) | Episode 3 (22 months) | Reference |
| ALT (U/L) | 1840 | 320 | 980 | 2100 | 7-45 |
| AST (U/L) | 2210 | 280 | 1140 | 2450 | 10-40 |
| Total bilirubin (μmol/L) | 340 | 95 | 210 | 380 | < 21 |
| GGT (U/L) | 18 | 22 | 20 | 24 | < 50 |
| ALP (U/L) | 95 | 80 | 88 | 91 | < 350 |
| Albumin (g/dL) | 2.9 | 3.4 | 3.1 | 2.8 | 3.5-5.0 |
| INR | 2.8 | 1.6 | 2.1 | 3.1 | < 1.2 |
| WBC (× 109/L) | 2.1 | 3.8 | 2.4 | 2.0 | 5-15 |
| Haemoglobin (g/dL) | 8.2 | 9.5 | 8.9 | 8.0 | 11-14 |
| Platelets (× 109/L) | 68 | 102 | 75 | 62 | 150-400 |
Table 3 Reported cases of SCYL1-associated recurrent acute liver failure and neurological manifestations (literature review)
| Ref. | Patient (s) | Genotype | Key phenotypic features |
| Schmidt et al[8] | 2 siblings (European), 1 female (Cuban) | Compound heterozygous: P.Val313Cysfs*6, p.Ala504Profs*15; p.Gln546*, c.1230+1G>A | RALF, chronic fibrosis, CVA, intention tremor, neurogenic stutter |
| Lenz et al[1] | 7 pediatric patients | Homozygous nonsense (p.Gln628*, p.Glu86*, p.Gln57*) and missense (p.Asp478Gly, p.Ala105Val) | Named CALFAN. Low-GGT cholestasis, RALF; variable neuro-phenotypes |
| Incecik et al[6] | 10 years male (Turkish) | Homozygous: C.1420C>T (exon 11) | First Turkish case; RALF, delayed motor milestones, axonal neuropathy, CVA |
| Shohet et al[7] | 28 months male, 18 years aunt (Ashkenazi Jewish) | Homozygous synonymous: C.459C>T (exon 4) | Aberrant splicing. RALF, short stature, motor neuropathy |
| Li et al[4] | 7 years male (Han Chinese) | Homozygous frameshift: P.H32Gfs*20 (exon 1) | First East Asian case. RALF, late-onset skeletal disease, mild neuro-impairment |
| Spagnoli et al[9] | 7 years female | Homozygous 1-bp duplication: P.Cys512 Leufs*8 | Predominant neurologic phenotype; recurrent respiratory failure |
| McNiven et al[10] | 13 years male, 9 years female (siblings) | Compound heterozygous: P.Asn133 Lysfs*136 and multi-exon deletions (exons 7-8) | Severe hepatic phenotype requiring liver transplantation; later tremor and cognitive dysfunction |
| Isa et al[11] | 5 years male (Bahraini) | Homozygous nonsense: C.895A>T (exon 7) | RALF triggered by fever, global developmental delay, progressive inability to walk |
| Zare et al[12] | 11 years female (Iranian) | Homozygous mutation in exon 11 | Recurrent liver failure, compensated cirrhosis, gait disability, dysarthria, clubfoot |
| Kazem et al[13] | 8years female, 9 years male (Kuwaiti Siblings) | Homozygous splice site: C.1386+1G>A | Intrafamilial variability: Girl had RALF; brother remains asymptomatic |
| Suenera et al[14] | 6 years female (Indian) | Homozygous frameshift: P.Lys249ArgfsTer58 (exon 6) | Overlap with PFIC. Also carried LPAR6 mutation explaining brittle hair |
| Present case | 19 months female (Arab) | Homozygous nonsense: C.1420C>T (p.Arg474*) (exon 11) | RALF × 3, low-GGT cholestasis, pancytopenia, tremors, fine motor delay; partial steroid response |
- Citation: Zourob D, Teneiji AA, Miqdady M, Al Atrash E. Recurrent acute liver failure in infancy - a novel SCYL1 mutation: A case report. World J Clin Pediatr 2026; 15(3): 120925
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/120925.htm
- DOI: https://dx.doi.org/10.5409/wjcp.120925